Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
biogen
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
3
×
indiana top stories
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aldeyra therapeutics
alexion pharmaceuticals
biotech
bristol-myers squibb
cancer
cancer immunotherapy
celgene
clinical trials
deals
eisai
eli lilly
What
alzheimer’s
3
×
bio
drug
roundup
prices
week
aducanumab
amyloid
angst
annual
assessed
attention
bagged
billions
biogen
biogen’s
biotech
brammer
communities
companies
conference
different
effects
esmo
europe
fail
failure
felt
gene
germany
hosted
increases
investment
latest
lost
munich
nash
news
pharmaceutical
plan
Language
Current search:
alzheimer’s
×
" indiana blog main "
×
" indiana top stories "
×
biogen
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More